MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?-Reference-Cited by-同舟云学术

MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?

Published:2023-04-22 Issue:10 Volume:33 Page:7168-7177
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Sella Tamar^ORCID,Simor Bar,Adler - Levy Yael,Maly Bella,Kadouri Luna,Carmon Einat

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-023-09640-x.pdf

Reference33 articles.

1. Mieog JS, van der Hage JA, van de Velde CJ (2007) Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 94(10):1189–1200

2. Untch M, Konecny GE, Paepke S, Minckwitz GV (2014) Current and future role of neoadjuvant therapy for breast cancer. Breast 23(5):526–537

3. Mamtani A,Sevilimedu V, Le T et al (2022) Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy? Cancer 128(3):471–478

4. Mamtani A, Barrio AV, King TA et al (2016) How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol 23(11):3467–3474

5. Montagna G, Mamtani A, Knezevic A, Brogi E, Barrio AV, Morrow M (2020) Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy. Ann Surg Oncol 27(11):4515–4522

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancers;European Journal of Radiology;2024-09

2. Actualisation des indications chirurgicales et des indicateurs de qualité et sécurité des soins dans la prise en charge des carcinomes mammaires invasifs;Gynécologie Obstétrique Fertilité & Sénologie ;2023-12